Vol 68, No 6 (2010)
Chorzy trudni nietypowi
Published online: 2010-06-17
Ivabradine as a heart rate-lowering agent in a patient with end-stage renal failure after heart transplantation
DOI: 10.33963/v.kp.79710
Kardiol Pol 2010;68(6):684-686.
Abstract
A 56 year-old woman with a transplanted heart, with arterial hypertension and chronic pulmonary obstructive disease, was
hospitalised because of palpitations, dyspnea, chest pain and oedema. After cyclosporine treatment she was diagnosed with
renal failure, which was treated by hemodialysis. Heart rate (HR) at admission was 100, mean HR in 24-hour Holter monitoring
was 106 bpm. Ivabradine was added to the treatment. The dose of 2.5 mg bid was doubled after three days. Mean HR in
control Holter monitoring was 81. Ivabradine was well tolerated in this patient. The clinical benefits were observed soon after
application and maintained during the follow-up.
Kardiol Pol 2010; 68, 6: 684-686
Kardiol Pol 2010; 68, 6: 684-686
Keywords: heart transplantationivabradinerenal failure